DHR Summary

  1. NYSE
  2. >
  3. DHR
TickerDHR
DescriptionDANAHER CORP
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.
ExchangeNYSE
TypeStock
SectorHealthcare
Employees60,000
Next Earnings DateOctober 22nd, 2020
IV32.153437%
IV Percentile79th
IV Rank16.51%
IV Skew9.200661
IV Skew Percentile43rd
IV Skew SentimentNeutral
Option Volume2,778
Volume3,761,534
Price$226.55
Previous Close$227.03
52-Week High$229.4499
52-Week Low$119.60
50-Day Moving Avg.$210.54
200-Day Moving Avg.$175.57
10-Day Avg. Volume1,981,250
20-Day Avg. Volume2,005,411
30-Day Avg. Volume2,042,284
3-Month Avg. Volume2,016,216
PE56.52273
EPS$3.96
Outstanding Shares709,409,000
Float629,301,826
Market Capitalization$158,786,980,000
CurrencyUSD
UpdatedOctober 21st, 2020